ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPRO CORPORATION
  3. Financials
  4. Cash and cash equivalents

NIPRO CORPORATION (8086)

Market cap
¥294.7B
P/E ratio
18.7x
Nipro manufactures medical devices, generic pharmaceuticals, and pharma packaging materials, serving healthcare institutions with products like dialysis equipment, syringes, and glass vials.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 202697,835-8.28%
Mar 31, 2025106,668+7.02%
Mar 31, 202499,667+11.14%
Mar 31, 202389,678-5.94%
Mar 31, 202295,342+5.61%
Mar 31, 202190,274-5.89%
Mar 31, 202095,925-25.89%
Mar 31, 2019129,438-8.81%
Mar 31, 2018141,940+15.22%
Mar 31, 2017123,188-2.75%
Mar 31, 2016126,667+12.22%
Mar 31, 2015112,871

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat